EMPLOYMENT AGREEMENTEmployment Agreement • March 26th, 2014 • Quotient LTD • In vitro & in vivo diagnostic substances • Delaware
This Employment Agreement (“Employment Agreement”) is entered into as of March 5, 2014 (the “Effective Date”), by and between Quotient Limited (“Employer”), or such affiliate of Employer as its Chairman may designate, and Stephen Unger (“Executive”) (collectively, the “Parties”).
CONFIDENTIAL THE TECHNOLOGY PARTNERSHIP PLC AND QBD (QS-IP) LIMITED INTELLECTUAL PROPERTY RIGHTS AGREEMENTIntellectual Property Rights Agreement • March 26th, 2014 • Quotient LTD • In vitro & in vivo diagnostic substances
CONFIDENTIAL THE TECHNOLOGY PARTNERSHIP PLC AND QBD (QS-IP) LIMITED MASTER DEVELOPMENT AGREEMENTMaster Development Agreement • March 26th, 2014 • Quotient LTD • In vitro & in vivo diagnostic substances
STRATEC DEVELOPMENT AGREEMENTDevelopment Agreement • March 26th, 2014 • Quotient LTD • In vitro & in vivo diagnostic substances
THIS STRATEC DEVELOPMENT AGREEMENT is effective as of January 7th, 2014 (the “Effective Date”) and Is made by and between STRATEC Biomedical AG, a stock corporation formed under the laws of the Federal Republic of Germany, having its principal place of business at Gewerbestrasse 37, D-75217 Birkenfeld-Graefenhausen, Germany (hereinafter referred to as “STRATEC”), and QBD (QS IP) Ltd, having its registered office at PO Box 1075, Elizabeth House, 9 Castle Street, St Helier JE4 2QP, Jersey, Channel Islands (hereinafter referred to as “QUOTIENT”, and both STRATEC and QUOTIENT are referred to as the Parties
